Production (Stage)
MIRA Pharmaceuticals, Inc.
MIRA
$1.40
$0.032.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.78M | -2.40M | -2.04M | -1.69M | -1.72M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 874.80K | 546.80K | 269.00K | 604.80K | 500.20K |
| Change in Net Operating Assets | -721.10K | 47.90K | -67.30K | 222.60K | 168.00K |
| Cash from Operations | -1.63M | -1.81M | -1.84M | -863.90K | -1.05M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 14.50K | -14.50K | 24.30K | -24.30K |
| Issuance of Common Stock | 3.40K | 478.90K | 3.13M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 47.70K | 134.70K | -- |
| Cash from Financing | 3.40K | 493.40K | 3.16M | 159.00K | -24.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.63M | -1.31M | 1.32M | -704.90K | -1.07M |